Evolus Inc. (EOLS) Live Share Price, Invest From India

Evolus Inc. Stock Performance

as on July 3, 2026 at 2:16 pm IST

Day's Low
$6.70
Day's Price Range
$6.90
$6.90
2.90%
Downside
52 Week's Low
52 Week's High
$3.86
52-Week Price Range
$10.20
$6.90
44.06%
Downside
47.83%
Upside

Evolus Inc. share price movements today

Previous Close: $6.74
Open: $6.82
Volume: 550.6K
Day's Low - High: $6.70 - $6.90
52 Week Low - High: $3.86 - $10.20

Evolus Inc. Historical Returns

1 Month Return: + 3.45 %
3 Month Return: + 65.87 %
1 Year Return: -25.57 %
3 Year Return: -3.77 %
5 Year Return: -46.26 %

Evolus Inc. Stock Fundamentals & Key Indicators

Check Evolus Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$454.4M

EPS (TTM)

-0.094

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-23.2M

Revenue (TTM)

301.8M

Profit Margin

-14.39%

Return On Equity TTM

-18729.61%

Evolus Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evolus Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Evolus Inc.	BUY	$454.4M	-46.26%	NA	-14.39%	NA
United Therapeutics Corporation	BUY	$23.6B	200.05%	20.57	40.62%	NA
Viatris Inc.	HOLD	$19.4B	17.69%	NA	-2.04%	2.97%
Haleon plc (ADR)	BUY	$43.2B	NA	20.04	15.11%	1.97%
ZOETIS INC.	BUY	$31.4B	-61.45%	12.26	28.04%	2.8000000000000003%

See all

Stock Returns calculator for Evolus Inc. Stock including INR - Dollar returns

The Evolus Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Evolus Inc. investment value today

Current value as on today

₹82,627

Returns

-₹17,373

(-17.37%)

Returns from Evolus Inc. Stock

-₹25,566 (-25.57%)

Dollar Impact

₹8,193 (+8.19%)

Analyst Recommendation on Evolus Inc. Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Evolus Inc.. Average target price of $14.67

Evolus Inc. Share Price Target

Get share price movements and forecasts by analysts on Evolus Inc..

What analysts predicted

52.97%UPSIDE

Target Price

$14.67

Current Price

$6.9

Analyzed by

14 Analysts

Target

$14.67

Evolus Inc. target price $14.67, a slight upside of 52.97% compared to current price of $6.9. According to 14 analysts rating.

Indian Investors' Interest in Evolus Inc. Stock

Search interest for Evolus Inc. Stock has decreased by -71% in the last 30 days, reflecting a downward trend in search activity.

Time period: June 6, 2026 to July 6, 2026

Change:-71% versus previous 30 day period

Evolus Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	60	59	66	61	78	68	69	68	90	73
Gross Profit	38	40	47	42	50	46	45	45	59	47
Operating Income	-8	-8	-7	-15	-2	-15	-10	-11	0	-6
EBITDA	-3	-6	-5	-13	0	-12	-7	-9	7	-3
Interest Expense	4	4	4	4	4	4	7	4	3	3
Depreciation	1	1	1	1	1	1	2	2	2	2
Income Before Tax	-11	-13	-11	-19	-6	-18	-17	-15	0	-10
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-11	-13	-11	-19	-6	-18	-17	-15	0	-10
Net Profit Margin	-19.40%	-22.09%	-16.96%	-31.38%	-8.60%	-27.57%	-24.70%	-22.82%	0.14%	-14.59%

Evolus Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	34	56	99	148	202	266	297
Gross Profit	0	0	-	26	38	56	89	140	182	192
Operating Income	-19	-11	-46	-98	-153	-44	-65	-49	-34	-37
EBITDA	-19	-11	-45	-92	-144	-39	-53	-41	-25	-22
Interest Expense	-	-	0	7	10	1	9	13	18	19
Depreciation	-	0	0	5	7	6	4	5	6	8
Income Before Tax	-19	-11	-46	-105	-162	-46	-74	-61	-49	-50
Income Tax Expense	0	-7	0	-15	0	0	0	0	0	0
Net Income	-20	-4	-46	-90	-163	-46	-74	-61	-50	-51
Net Profit Margin	0.00%	0.00%	0.00%	-257.79%	-288.31%	-46.96%	-50.07%	-30.52%	-18.94%	-17.38%

Evolus Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-13	-11	-19	-6	-18	-17	-15	0	-10
Operating Cash Flow	-10	-6	-5	4	-15	-24	-14	12	-9
Investing Cash Flow	0	-1	-1	-1	-1	-2	-2	-2	-1
Financing Cash Flow	45	4	-1	-1	-1	20	-1	0	7
Change in Cash	34	-3	-8	1	-19	-6	-18	10	-4

Evolus Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-4	-46	-90	-163	-46	-74	-61	-50	-51
Operating Cash Flow	-13	-25	-93	-57	-33	-84	-34	-17	-42
Investing Cash Flow	0	0	-23	12	4	-2	-1	-4	-8
Financing Cash Flow	13	118	133	38	73	-4	44	47	17
Change in Cash	0	93	16	-7	43	-92	8	24	-33

Global Institutional Holdings in Evolus Inc.

Funds	Holdings
Altium Capital Management, LP	0.46%
Soleus Capital Management, L.P.	3.41%
Millennium Management LLC	2.22%
Geode Capital Management, LLC	2.1%
Morgan Stanley - Brokerage Accounts	1.11%

See all

Insights on Evolus Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, EOLS has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 months, EOLS stock has moved up by 65.9%
NO EFFECT
Against Peers
In the last 1 year, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 103.4% return, outperforming this stock by 129.0%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 130.0K → -10.67M (in $), with an average decrease of 8310.8% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 90.3M → 73.13M (in $), with an average decrease of 19.0% per quarter

About Evolus Inc.

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Organisation	Evolus Inc.
Headquarters	520 Newport Center Drive, Newport Beach, CA, United States, 92660
Industry	Drug Manufacturers - Specialty & Generic
CEO	Mr. David Moatazedi
E-voting on shares	Click here to vote

Key Management of Evolus Inc.

Name	Title
Ms. Tatjana Mitchell	Chief Financial Officer
Dr. Rui Avelar C.CFP, Dip.SportMed, M.D.	Chief Medical Officer and Head of Research & Development
Mr. Nareg Sagherian	Head of Global Investor Relations & Corporate Communications
Mr. Kurt Knab	Senior Vice President of Sales
Ms. Jessica Novak	Senior Vice President of Human Resources
Mr. Jeffrey J. Plumer	Corporate Secretary
Mr. David Moatazedi	President, CEO & Director

FAQs

What is Evolus Inc. share price today?

Evolus Inc. share price today is $6.90 as on July 3, 2026 at 8:46 am IST at the close of the market. Evolus Inc. share today touched a day high of $6.90 and a low of $6.70.

What is the 52 week high and 52 week low for Evolus Inc. share?

Evolus Inc. share touched a 52 week high of $10.20 on July 24, 2025 and a 52 week low of $3.86 on March 30, 2026. Evolus Inc. stock price today i.e. July 3, 2026 at 8:46 am IST is closed at $6.90,which is 32.35% down from its 52 week high and 78.76% up from its 52 week low.

What is Evolus Inc.'s market capitalisation today?

Evolus Inc. market capitalisation is $0.00T as on July 3, 2026 at 8:46 am IST.

How to invest in Evolus Inc. Stock (EOLS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Evolus Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evolus Inc. Shares that will get you 0.2174 shares as per Evolus Inc. share price of $6.90 per share as on July 3, 2026 at 8:46 am IST.

What is the minimum amount required to buy Evolus Inc. Stock (EOLS) from India?

Indian investors can start investing in Evolus Inc. (EOLS) shares with as little as ₹95.2 or $1 (as of July 6, 2026 at 4:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Evolus Inc. stock (as per the Rupee-Dollar exchange rate as on July 6, 2026 at 4:41 pm IST). Based on Evolus Inc. share’s latest price of $6.90 as on July 3, 2026 at 8:46 am IST, you will get 1.4493 shares of Evolus Inc.. Learn more about fractional shares .

What are the returns that Evolus Inc. has given to Indian investors in the last 5 years?

Evolus Inc. stock has given -46.26% share price returns and 28.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?